TONIX PHARMACEUTICALS HOLDING CORP. Goodwill, Acquired During Period
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Goodwill, Acquired During Period of $965.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2024-04-01
- TONIX PHARMACEUTICALS HOLDING CORP. goodwill, acquired during period for the quarter ending 2023-12-31 was $0.00.
- TONIX PHARMACEUTICALS HOLDING CORP. goodwill, acquired during period for the quarter ending 2023-09-30 was $0.00.
- TONIX PHARMACEUTICALS HOLDING CORP. goodwill, acquired during period for fiscal 2023 was $965.00K.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $965.00K 10-K · filed 2024-04-01 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $965.00K 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $965.00K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |